Skip to content

Short- and Long-term Behavioral, Cognitive and Motor Outcomes of Frameless Deep Brain Stimulation in Patients With Parkinson's Disease: a Prospective Observational Study

Short- and Long-term Behavioral, Cognitive and Motor Outcomes of Frameless Deep Brain Stimulation in Patients With Parkinson's Disease: a Prospective Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05752656
Enrollment
100
Registered
2023-03-03
Start date
2022-01-12
Completion date
2034-01-01
Last updated
2023-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

The main objective of the study is to evaluate the improvement in quality of life after deep brain stimulation surgery with frameless technique by comparing the PDQ-39 scale score at baseline (before surgery) and one year after surgery.

Interventions

Clinical examinations and administration of clinical scales

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of idiopathic Parkinson's disease according to Movement Disorder Society (MDS) criteria; * patients who are candidates for deep brain stimulation intervention, according to the international criteria of the Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

Exclusion criteria

\- patients unable to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Improvement of quality of lifeOne yearEvaluation of the PDQ-39 scale score at baseline (before surgery) and one year after surgery.

Countries

Italy

Contacts

Primary ContactFrancesco Bove, MD
francesco.bove@policlinicogemelli.it+390630156433

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026